BERNOCCHI, OTTAVIA
 Distribuzione geografica
Continente #
NA - Nord America 179
EU - Europa 161
AS - Asia 142
OC - Oceania 1
SA - Sud America 1
Totale 484
Nazione #
US - Stati Uniti d'America 178
SE - Svezia 76
HK - Hong Kong 50
CN - Cina 32
IT - Italia 32
SG - Singapore 31
VN - Vietnam 18
BG - Bulgaria 14
DE - Germania 11
IE - Irlanda 10
MY - Malesia 10
GB - Regno Unito 6
FR - Francia 5
BE - Belgio 3
BO - Bolivia 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
FI - Finlandia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 484
Città #
Chandler 58
Hong Kong 50
Singapore 24
Princeton 20
Dong Ket 18
Sofia 14
Trieste 12
Beijing 10
Dublin 10
Redmond 7
Santa Clara 6
Wilmington 6
Ann Arbor 5
Bremen 5
Fairfield 4
Ashburn 3
Brussels 3
London 3
Milan 3
Woodbridge 3
Boardman 2
Columbus 2
Rende 2
San Diego 2
Taranto 2
Auckland 1
Buffalo 1
Cagliari 1
Chicago 1
Cologne 1
Dallas 1
Espoo 1
Garden City 1
La Paz 1
Livorno 1
Modena 1
Norwalk 1
Paris 1
Riyadh 1
Seattle 1
Stockholm 1
Tallinn 1
Toenisvorst 1
Toronto 1
Totale 293
Nome #
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 67
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer 58
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: A retrospective exploratory analysis of the BALLET study 56
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis 56
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial 51
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 47
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer 46
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment 45
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study 41
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature 37
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 18
Totale 522
Categoria #
all - tutte 3.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022165 4 53 25 16 1 6 4 3 20 11 1 21
2022/2023176 24 39 18 13 19 29 3 10 9 0 10 2
2023/2024119 5 9 4 5 8 9 38 26 0 2 8 5
2024/202562 2 26 23 11 0 0 0 0 0 0 0 0
Totale 522